Author:
Kim S.,Jary M.,Mansi L.,Benzidane B.,Cazorla A.,Demarchi M.,Nguyen T.,Kaliski A.,Delabrousse E.,Bonnetain F.,Letondal P.,Bosset J.F.,Valmary-Degano S.,Borg C.
Reference20 articles.
1. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000;Johnson;Cancer,2004
2. Anal carcinoma, version 2.2012: featured updates to the NCCN guidelines;Benson;J Natl Compr Canc Netw,2012
3. Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal;Wilking;Cancer Chemother Pharmacol,1985
4. Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and bleomycin-CCNU in patients with advanced cancer of the anal canal: an eastern cooperative oncology group study E7282;Jhawer;Invest New Drugs,2006
5. Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a phase II trial;Hainsworth;Cancer,2001
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献